1.51
Schlusskurs vom Vortag:
$1.56
Offen:
$1.56
24-Stunden-Volumen:
1.98M
Relative Volume:
0.84
Marktkapitalisierung:
$1.20B
Einnahmen:
$711.41M
Nettoeinkommen (Verlust:
$-133.73M
KGV:
-7.9474
EPS:
-0.19
Netto-Cashflow:
$-199.99M
1W Leistung:
-3.09%
1M Leistung:
+7.22%
6M Leistung:
+11.16%
1J Leistung:
+2.84%
Opko Health Inc Stock (OPK) Company Profile
Firmenname
Opko Health Inc
Sektor
Branche
Telefon
305-575-4181
Adresse
4400 BISCAYNE BLVD., MIAMI, FL
Vergleichen Sie OPK mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
OPK
Opko Health Inc
|
1.51 | 1.24B | 711.41M | -133.73M | -199.99M | -0.19 |
![]()
TMO
Thermo Fisher Scientific Inc
|
524.70 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
![]()
DHR
Danaher Corp
|
202.45 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
![]()
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
136.63 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
![]()
IQV
Iqvia Holdings Inc
|
198.13 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-25 | Eingeleitet | JP Morgan | Neutral |
2023-06-29 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
2022-12-15 | Eingeleitet | H.C. Wainwright | Buy |
2022-01-24 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
2021-06-21 | Eingeleitet | Ladenburg Thalmann | Buy |
2019-11-25 | Eingeleitet | Piper Jaffray | Overweight |
2018-03-02 | Herabstufung | JP Morgan | Neutral → Underweight |
2017-09-14 | Herabstufung | JP Morgan | Overweight → Neutral |
2016-06-21 | Bestätigt | Standpoint Research | Buy |
2016-06-03 | Eingeleitet | Standpoint Research | Buy |
2016-03-31 | Bestätigt | Barrington Research | Outperform |
2015-10-16 | Eingeleitet | JP Morgan | Overweight |
2015-09-11 | Herabstufung | Jefferies | Buy → Hold |
2015-03-03 | Herabstufung | Oppenheimer | Outperform → Perform |
2014-05-12 | Bestätigt | Oppenheimer | Outperform |
2014-03-14 | Eingeleitet | Oppenheimer | Outperform |
2013-11-13 | Bestätigt | Ladenburg Thalmann | Buy |
2013-05-30 | Bestätigt | Ladenburg Thalmann | Buy |
2012-10-22 | Eingeleitet | Barrington Research | Outperform |
2011-12-01 | Bestätigt | Ladenburg Thalmann | Buy |
2011-07-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Opko Health Inc Aktie (OPK) Neueste Nachrichten
OPKO Health (NASDAQ:OPK) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Clinical Laboratory Tests Market See Incredible Growth 2025-2032 | ARUP Laboratories, OPKO Health, Inc., UNILABS - industrytoday.co.uk
Smart tools for monitoring OPKO Health Inc.’s price actionJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com
Real time pattern detection on OPKO Health Inc. stock2025 Technical Overview & Low Drawdown Trading Strategies - newser.com
NextPlat Issues CEO Shareholder Update Letter - Benzinga
OPKO Health Experiences Evaluation Revision Amid Mixed Market Signals and Performance Trends - Markets Mojo
OPKO acquiring company from Barcelona - Law.com
Can machine learning forecast OPKO Health Inc. recoveryPortfolio Return Summary & Safe Entry Zone Identification - newser.com
How OPKO Health Inc. stock performs in weak economyJuly 2025 Big Picture & Smart Investment Allocation Tips - newser.com
Why OPKO Health Inc. stock attracts global investorsMarket Volume Summary & Reliable Momentum Entry Alerts - newser.com
Technical signs of recovery in OPKO Health Inc.July 2025 Highlights & Fast Moving Market Watchlists - newser.com
How OPKO Health Inc. (XCY) stock reacts to stronger dollarJuly 2025 Catalysts & Weekly Chart Analysis and Guides - newser.com
How to manage a losing position in OPKO Health Inc.Weekly Trend Recap & Expert Curated Trade Setup Alerts - newser.com
Ranking OPKO Health Inc. among high performing stocks via toolsQuarterly Earnings Summary & Entry Point Confirmation Alerts - newser.com
What institutional flow reveals about OPKO Health Inc.Portfolio Update Report & Breakout Confirmation Trade Signals - newser.com
OPKO Health (OPK): Valuation Insights as Clinical Pipeline Progress and Asset Sales Draw Investor Focus - Sahm
Washington Growth Strategies LLC Has $1.79 Million Position in OPKO Health, Inc. $OPK - MarketBeat
OPKO Health (OPK) Is Up 7.7% After Advancing Immuno-Oncology Pipeline and CEO Boosts Stake Has the Bull Case Changed? - Sahm
Why OPKO Health (OPK) Is Up 7.7% After Advancing Immuno-Oncology Pipeline and Notable Insider Buying - Sahm
Opko Health (OPK) Reports Fiscal Q2 2025 Results - MSN
What machine learning models say about OPKO Health Inc.July 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
OPKO Health, Inc. (OPK)’s ModeX Division Pushes Four Immuno-Oncology Candidates into Phase 1 - Yahoo Finance
What analysts say about OPKO Health Inc stockCandlestick Trading Patterns & Minimal Investment Profits - earlytimes.in
Labcorp to buy certain assets of OPKO unit BioReference Health - MSN
12 Healthcare Stocks with Insider Buying in 2025 - Insider Monkey
OPK Stock Gains Following Q4 Earnings Beat, Gross Margin Expands - MSN
Down Syndrome Market: Epidemiology, Therapies, Companies, DelveInsight | AC Immune, Annovis Bio, Alzheon, OPKO Health, Inc., Aelis Farma - Barchart.com
44% of OPKO Health, Inc. (NASDAQ:OPK) is owned by insiders, and they've been buying recently - Yahoo Finance
Opko Health, Inc. (OPK) Stock Analysis: Unlocking a Potential 151% Upside with Strategic Healthcare Innovations - DirectorsTalk Interviews
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Voya Investment Management LLC Lowers Position in OPKO Health, Inc. $OPK - MarketBeat
Finanzdaten der Opko Health Inc-Aktie (OPK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Opko Health Inc-Aktie (OPK) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 10 '25 |
Buy |
1.36 |
125,000 |
169,712 |
214,001,448 |
FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 08 '25 |
Buy |
1.48 |
125,000 |
184,650 |
213,876,448 |
FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 01 '25 |
Buy |
1.65 |
100,000 |
164,850 |
213,751,448 |
FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 28 '25 |
Buy |
1.70 |
150,000 |
254,385 |
213,651,448 |
FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 17 '25 |
Buy |
1.74 |
200,000 |
347,820 |
213,501,448 |
FROST PHILLIP MD ET AL | CEO & Chairman |
Feb 28 '25 |
Buy |
1.71 |
67,434 |
115,312 |
213,301,448 |
FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 28 '25 |
Buy |
1.47 |
47,537 |
70,060 |
213,234,014 |
FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 17 '25 |
Buy |
1.47 |
150,000 |
220,425 |
213,186,477 |
FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 15 '25 |
Buy |
1.48 |
500,000 |
740,850 |
213,036,477 |
FROST PHILLIP MD ET AL | CEO & Chairman |
Dec 13 '24 |
Buy |
1.59 |
125,000 |
199,375 |
212,536,477 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):